SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years
Louise C Rowntree,Jennifer Audsley,Lilith F Allen,Hayley A McQuilten,Ruth R Hagen,Priyanka Chaurasia,Jan Petersen,Dene R Littler,Hyon-Xhi Tan,Lydia Murdiyarso,Jennifer R Habel,Isabelle J H Foo,Wuji Zhang,Elizabeth R V Ten Berge,Hanujah Ganesh,Prathanporn Kaewpreedee,Kelly W K Lee,Samuel M S Cheng,Janette S Y Kwok,Dhilshan Jayasinghe,Stephanie Gras,Jennifer A Juno,Adam K Wheatley,Stephen J Kent,Jamie Rossjohn,Allen C Cheng,Tom C Kotsimbos,Jason A Trubiano,Natasha E Holmes,Ken Ka Pang Chan,David S C Hui,Malik Peiris,Leo L M Poon,Sharon R Lewin,Peter C Doherty,Irani Thevarajan,Sophie A Valkenburg,Katherine Kedzierska,Thi H O Nguyen
DOI: https://doi.org/10.1073/pnas.2411428121
2024-09-24
Abstract:Long COVID occurs in a small but important minority of patients following COVID-19, reducing quality of life and contributing to healthcare burden. Although research into underlying mechanisms is evolving, immunity is understudied. SARS-CoV-2-specific T cell responses are of key importance for viral clearance and COVID-19 recovery. However, in long COVID, the establishment and persistence of SARS-CoV-2-specific T cells are far from clear, especially beyond 12 mo postinfection and postvaccination. We defined ex vivo antigen-specific B cell and T cell responses and their T cell receptors (TCR) repertoires across 2 y postinfection in people with long COVID. Using 13 SARS-CoV-2 peptide-HLA tetramers, spanning 11 HLA allotypes, as well as spike and nucleocapsid probes, we tracked SARS-CoV-2-specific CD8+ and CD4+ T cells and B-cells in individuals from their first SARS-CoV-2 infection through primary vaccination over 24 mo. The frequencies of ORF1a- and nucleocapsid-specific T cells and B cells remained stable over 24 mo. Spike-specific CD8+ and CD4+ T cells and B cells were boosted by SARS-CoV-2 vaccination, indicating immunization, in fully recovered and people with long COVID, altered the immunodominance hierarchy of SARS-CoV-2 T cell epitopes. Meanwhile, influenza-specific CD8+ T cells were stable across 24 mo, suggesting no bystander-activation. Compared to total T cell populations, SARS-CoV-2-specific T cells were enriched for central memory phenotype, although the proportion of central memory T cells decreased following acute illness. Importantly, TCR repertoire composition was maintained throughout long COVID, including postvaccination, to 2 y postinfection. Overall, we defined ex vivo SARS-CoV-2-specific B cells and T cells to understand primary and recall responses, providing key insights into antigen-specific responses in people with long COVID.